Surrozen Inc (SRZN)
9.54
-0.61
(-6.01%)
USD |
NASDAQ |
May 17, 16:00
9.54
0.00 (0.00%)
After-Hours: 16:09
Surrozen Total Liabilities (Quarterly): 6.58M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.58M |
| December 31, 2023 | 8.145M |
| September 30, 2023 | 8.442M |
| June 30, 2023 | 8.941M |
| March 31, 2023 | 11.16M |
| December 31, 2022 | 13.43M |
| Date | Value |
|---|---|
| September 30, 2022 | 13.94M |
| June 30, 2022 | 14.43M |
| March 31, 2022 | 14.99M |
| December 31, 2021 | 27.47M |
| September 30, 2021 | 26.90M |
| December 31, 2020 | 14.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.58M
Minimum
Mar 2024
27.47M
Maximum
Dec 2021
14.10M
Average
13.69M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.72M |
| Shareholders Equity (Quarterly) | 30.14M |